RE: Oxford Nanopore10 Jul 2019 16:02
Thanks for the correction. I agree Woodford does have too much influence here and in some other companies, but I do back his strategy. He’s been unfortunate in that circumstances beyond his control have hindered his performance. That’s not to say he’s backed some duds. But I admire his steadfast belief in some companies like this, Xeros, Avacta, Reneuron which are great prospects. He doubles down when things aren’t going so well.
However, a fresh approach and less concentrated stranglehold on the company is better for us other shareholders